Scopus BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Cash & Equivalents	0.12	7.94	1.83	0.04	0	0.16
Cash & Cash Equivalents	0.12	7.94	1.83	0.04	0	0.16
Cash Growth	-98.43%	333.54%	4885.71%	2113.67%	-98.95%	-
Receivables	0	0	0	0	0.03	0.05
Inventory	0	0	0	0.73	0	0
Other Current Assets	0.27	0.24	0.14	0	0.1	-
Total Current Assets	0.39	8.18	1.97	0.77	0.13	0.21
Property, Plant & Equipment	0	0	0	0	0	0
Total Long-Term Assets	0	0	0	0	0	0
Total Assets	0.39	8.19	1.97	0.77	0.13	0.21
Current Debt	0	0	2.28	0	0	0
Other Current Liabilities	7.45	4.17	1.52	0.85	0.14	-
Total Current Liabilities	7.45	4.17	3.81	0.85	0.14	0.11
Total Liabilities	7.45	4.17	3.81	0.85	0.14	0.11
Total Debt	0	0	2.28	0	0	0
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Retained Earnings	-53.06	-41.46	-14.5	-3.64	-0.95	-0.26
Comprehensive Income	-0	-0.09	-0.07	-0.03	-0.01	0
Shareholders' Equity	-6.56	4.02	-1.83	-0.08	-0.01	0.1
Total Liabilities and Equity	0.39	8.19	1.97	0.77	0.13	0.21
Net Cash / Debt	0.12	7.94	-0.45	0.04	0	-
Net Cash / Debt Growth	-98.43%	-	-	2113.67%	-	-
Net Cash Per Share	0.01	0.46	-0.03	0.00	0.00	-
Working Capital	-7.06	4.01	-1.83	-0.09	-0.01	0.1
Book Value Per Share	-0.31	0.23	-0.14	-0.01	-0.00	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.